In addition, Accordi et al. [11] realized that prednisone is up-modulating the LCK proto-oncogene, Src family tyrosine kinase (LCK) activity in ALL patients with poor response to this drug. This evidence concerns the gene LCK and acute lymphoblastic leukemia.